Di-tert-butyl (R)-2-(2-hydroxyethyl)piperazine-1,4-dicarboxylate
98%
- Product Code: 229398
CAS:
2224423-03-2
| Molecular Weight: | 330.42 g./mol | Molecular Formula: | C₁₆H₃₀N₂O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 420.6±20.0 °C(Predicted) | |
| Density: | 1.108±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules requiring stereochemical control. Its protected piperazine core with a hydroxyethyl side chain allows for selective functionalization in multi-step organic syntheses. Commonly employed in the preparation of protease inhibitors and other therapeutic agents where the (R)-configuration plays a critical role in biological activity. The tert-butyl carbamate (Boc) groups provide stability during reactions and can be removed under mild acidic conditions, enabling further derivatization. Also utilized in medicinal chemistry for constructing drug candidates targeting central nervous system disorders and infectious diseases.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿8,480.00 |
+
-
|
| 250mg | 10-20 days | ฿14,420.00 |
+
-
|
Di-tert-butyl (R)-2-(2-hydroxyethyl)piperazine-1,4-dicarboxylate
Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules requiring stereochemical control. Its protected piperazine core with a hydroxyethyl side chain allows for selective functionalization in multi-step organic syntheses. Commonly employed in the preparation of protease inhibitors and other therapeutic agents where the (R)-configuration plays a critical role in biological activity. The tert-butyl carbamate (Boc) groups provide stability during reactions and can be removed under mild acidic conditions, enabling further derivatization. Also utilized in medicinal chemistry for constructing drug candidates targeting central nervous system disorders and infectious diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :